| Organism name | Aglaia forbesii |
|---|---|
| Genus | Aglaia |
| Family | Meliaceae |
| Kingdom | Plantae |
| Linked NCBI taxonomy name | Aglaia forbesii |
|---|---|
| Linked NCBI taxonomy ID | 306504 |
| Linked level | species |
| Family in NCBI taxonomy | Meliaceae |
|---|---|
| ID | 43707 |
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
| Plant class | rosids |
|---|---|
| ID | 71275 |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
|
C00019220
|
Lupenone
|
CHEMBL486393
CHEMBL575188 |
3 / 4 / 2 | No. 23 | No. 51 |
|
||
|
C00003749
|
Lupeol
/ Lupenol / (+)-Lupenol |
CHEMBL289191
CHEMBL459702 |
C010480
|
3 / 0 / 0 | 2 / 6 | No. 23 | No. 51 |
|
|
C00028187
|
Didesmethylrocaglamide
|
CHEMBL583207
|
1 / 0 / 0 | No. 449 |
|
|||
|
C00027821
|
Aglain B
/ (+)-Aglain B |
CHEMBL390463
|
No. 576 |
|
||||
|
C00027819
|
Aglaforbesin B
|
No. 576 |
|
|||||
|
C00027820
|
Aglain A
/ (+)-Aglain A |
CHEMBL390233
|
No. 576 |
|
||||
|
C00027818
|
Aglaforbesin A
|
No. 576 |
|
|||||
|
C00033769
|
Desacetylpyramidaglain D
/ (+)-Desacetylpyramidaglain D |
CHEMBL2204410
|
No. 576 |
|
||||
|
C00033767
|
Desacetylpyramidaglain A
/ (+)-Desacetylpyramidaglain A |
CHEMBL2204410
|
No. 576 |
|
||||
|
C00033768
|
Desacetylpyramidaglain C
/ (-)-Desacetylpyramidaglain C |
CHEMBL2204410
|
No. 576 |
|
||||
|
C00033545
|
23,24,25-Trihydroxycycloartan-3-one
/ (+)-23,24,25-Trihydroxycycloartan-3-one |
No. 804 |
|
|||||
|
C00033550
|
2beta,3beta-Dihydroxy-5alpha-pregn-17(E)-en-16-one
/ (-)-2beta,3beta-Dihydroxy-5alpha-pregn-17(E)-en-16-one |
No. 1223 |
|
|||||
|
C00033551
|
2beta,3beta-Dihydroxy-5alpha-pregn-17(Z)-en-16-one
|
No. 1223 |
|
|||||
|
C00000149
|
Spathulenol
|
CHEMBL518542
CHEMBL1774433 |
C013258
|
No. 1603 |
|
|||
|
C00034182
|
Pyramidatine
|
CHEMBL483414
|
No. 2973 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| Q8TDU6 | G-protein coupled bile acid receptor 1 | Steroid-like ligand receptor | C00019220 | 0 / 0 |
| P08047 | Transcription factor Sp1 | Unclassified protein | C00003749 | 0 / 0 |
| P11387 | DNA topoisomerase 1 | Isomerase | C00003749 | 0 / 0 |
| P11388 | DNA topoisomerase 2-alpha | Isomerase | C00003749 | 0 / 0 |
| Q04206 | Transcription factor p65 | Transcription Factor | C00028187 | 0 / 0 |
| P14679 | Tyrosinase | Oxidoreductase | C00019220 | 4 / 2 |
| Q96RI1 | Bile acid receptor | NR1H4 | C00019220 | 0 / 0 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 1499 | CTNNB1, CTNNB, MRD19, armadillo | catenin (cadherin-associated protein), beta 1, 88kDa |
C00003749
|
| 5728 | PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1 | phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48) |
C00003749
|
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D006528 | Carcinoma, Hepatocellular |
C00003749
|
| D009202 | Cardiomyopathies |
C00003749
|
| D006937 | Hypercholesterolemia |
C00003749
|
| D009374 | Neoplasms, Experimental |
C00003749
|
| D012878 | Skin Neoplasms |
C00003749
|
| D014947 | Wounds and Injuries |
C00003749
|